Pulmonary Hypertension: Symptoms, Right Heart Strain, and Therapy

Pulmonary Hypertension: Symptoms, Right Heart Strain, and Therapy

When you start feeling out of breath climbing stairs, or notice your ankles swelling for no clear reason, it’s easy to brush it off. Maybe you’re just getting older. Maybe you’re not fit enough. But if these symptoms stick around-especially if they get worse over months, not days-you could be dealing with something more serious: pulmonary hypertension.

Pulmonary hypertension (PH) isn’t just high blood pressure in the lungs. It’s a slow, silent process where the arteries carrying blood from your heart to your lungs narrow and stiffen. That forces your right ventricle to work harder and harder, until it starts to strain, stretch, and eventually fail. Left untreated, it can be deadly. But with early detection and the right treatment, many people live full, active lives today.

What Pulmonary Hypertension Really Means

Normal pulmonary artery pressure is around 8-20 mmHg. When it stays above 20 mmHg at rest-measured directly through right heart catheterization-you’re diagnosed with PH. This isn’t just a number. It’s a sign that your heart is fighting against stiff, clogged vessels. The blood can’t flow easily, so your right ventricle has to pump harder. Over time, that muscle thickens, enlarges, and loses its ability to contract properly. That’s right heart strain.

PH isn’t one disease. It’s grouped into five types by the World Health Organization:

  • Group 1: Pulmonary arterial hypertension (PAH)-the most severe, often genetic or idiopathic.
  • Group 2: Caused by left heart failure-like from a weak left ventricle.
  • Group 3: Linked to lung diseases-COPD, pulmonary fibrosis, long-term low oxygen.
  • Group 4: Chronic blood clots in the lungs (CTEPH).
  • Group 5: Unclear causes-like kidney disease, sarcoidosis, or blood disorders.

Knowing the group matters because treatment changes. Group 1 gets targeted drugs. Group 2 needs heart failure therapy. Group 4 might need surgery. Mislabeling it delays care.

Early Symptoms Are Easy to Miss

Most people don’t wake up one day with chest pain. PH creeps in. The first sign? Shortness of breath during normal activity. Not after running a marathon-after walking to the mailbox. Then comes fatigue. Then swelling in the legs or belly. Dizziness. Fainting. A racing heartbeat.

Doctors often mistake these for asthma, anxiety, or aging. A 2023 survey by the Pulmonary Hypertension Association found that 78% of patients were misdiagnosed for over a year. One man in Manchester thought he was just out of shape until his 6-minute walk distance dropped from 450 meters to 220 meters over 18 months. His GP said, “You need to exercise more.” A specialist later found his pulmonary pressure was 58 mmHg.

Physical exam clues matter too. A loud second heart sound (S2), a heave in the chest from the right ventricle pushing hard, or bulging neck veins (jugular venous distension) aren’t random. They’re signs your heart is under siege.

Right Heart Strain: The Hidden Killer

Pulmonary hypertension doesn’t kill because of lung damage. It kills because the right side of the heart gives out.

When the right ventricle strains, it changes shape. On echocardiogram, we look for:

  • Wall thickness over 5 mm
  • End-diastolic area bigger than 22 cm²
  • TAPSE under 17 mm (that’s how far the valve moves during a beat)

If TAPSE falls below 15 mm, your risk of death in the next year doubles. BNP and NT-proBNP blood levels tell the same story. Above 180 pg/mL for BNP or 1,400 pg/mL for NT-proBNP? That’s a red flag. One study showed patients with NT-proBNP over 2,000 had a 70% chance of dying within 12 months without treatment.

The 6-minute walk test is simple but brutal. Walk as far as you can in six minutes. If you cover less than 380 meters, your prognosis worsens. A 2020 analysis found these patients were over twice as likely to die or need hospitalization. That’s not just a number-it’s a warning.

A doctor inserting a glowing catheter into the heart while an echocardiogram shows abnormal readings, with an asthma inhaler fading away.

Diagnosis: Why Catheterization Still Matters

Echocardiograms are the first step. They’re non-invasive, quick, and widely available. But they’re not perfect. A 2019 study in Circulation found echocardiography overestimates pressure by 10-15 mmHg in over half the cases. That means people get falsely diagnosed-or worse, missed entirely.

Right heart catheterization is the gold standard. A thin tube is threaded from the groin or neck into the heart to measure pressure directly. It’s not risky for most. The chance of a serious complication? Less than 5%. But it’s still underused. Many clinics skip it because they rely on echo alone.

That’s a mistake. Dr. Nazzareno Galiè, who helped shape European guidelines, says: “Non-invasive methods cannot replace direct pressure measurement.” Why? Because only catheterization can tell if the problem is in the lungs (pre-capillary) or the heart (post-capillary). That difference changes everything.

Cardiac MRI gives the clearest picture of right ventricle size and function-but only 37% of PH centers in the U.S. have it. So most rely on echo, catheterization, and biomarkers together.

Therapy Has Changed Dramatically

Twenty years ago, PH meant a life expectancy of under three years. Today? Five-year survival is over 60%. That’s because we don’t treat PH with one drug anymore-we use combinations.

There are now 14 FDA-approved medications, grouped into five classes:

  • Phosphodiesterase-5 inhibitors: Sildenafil, tadalafil-help relax arteries.
  • Endothelin receptor antagonists: Bosentan, macitentan-block a chemical that narrows vessels.
  • Prostacyclin analogs: Epoprostenol, treprostinil-mimic a natural vasodilator. Often given by IV or inhalation.
  • Guanylate cyclase stimulators: Riociguat-boosts a signaling molecule that opens blood vessels.
  • Sotatercept: Approved in 2021-first drug to target the root cause in PAH by rebalancing growth signals.

Before 2015, most patients got one drug. Now, 68% of PAH patients start on two or three together. That’s because studies show combination therapy cuts hospitalizations and doubles survival time.

For Group 4 (CTEPH), surgery to remove clots (pulmonary thromboendarterectomy) can be curative. For others, lung transplant remains an option-but it’s rare, complex, and reserved for the worst cases.

A diverse medical team supporting a patient walking toward light, as a clock labeled '18 months delay' breaks behind them.

Why Care Needs to Be Specialized

PH isn’t something your local cardiologist can manage alone. It needs a team. A PH center includes:

  • A pulmonologist who knows the disease
  • A heart failure specialist
  • A pharmacist who handles complex drug interactions
  • A nurse coordinator who tracks labs, adjusts meds, and calls when something’s off
  • A social worker to help with insurance and costs

One study showed PH nurse coordinators cut hospital stays by 27%. Why? Because they catch problems early. A patient’s BNP rises from 200 to 450? The nurse calls the doctor before the patient feels dizzy.

Only about 35 centers in the U.S. are certified to treat PH. In the UK, the number is even smaller. Many patients wait months just to get an appointment. And even then, insurance delays can hold up life-saving drugs. One survey found 63% of patients waited over 30 days for approval on IV prostacyclin.

What’s Next? The Future of PH Care

New tools are coming. The 2022 revision lowered the diagnostic cutoff from 25 mmHg to 20 mmHg. That means more people will be caught earlier. The LIBERTY trial is testing let-7 microRNA as a blood marker for early right heart damage-before symptoms show.

Drugs targeting the heart’s energy use are in trials. Dichloroacetate, for example, helps the right ventricle burn fuel more efficiently. Phase 2 results are expected late 2024.

But the biggest challenge isn’t science-it’s access. A 2023 report showed minority patients wait 47% longer for diagnosis and have 32% higher death rates. That’s not biology. That’s systemic failure.

The Pulmonary Hypertension Association’s 2025 plan aims to cut diagnostic delays to under a year. How? By training primary care doctors to recognize the red flags: progressive breathlessness, unexplained right heart thickening on EKG, swelling without heart failure. If you’re a GP and someone says, “I’m winded climbing one flight of stairs,” don’t tell them to exercise more. Ask: Have they been tested for PH?”

Can pulmonary hypertension be cured?

In most cases, no-but it can be managed effectively. Group 4 PH (caused by chronic blood clots) can sometimes be cured with surgery. For other types, especially Group 1, there’s no cure yet. But with combination drug therapy, many patients live 10, 15, or even 20 years with good quality of life. The goal isn’t always cure-it’s slowing progression and keeping the heart working as long as possible.

Is pulmonary hypertension the same as regular high blood pressure?

No. Regular high blood pressure (hypertension) affects the arteries throughout the body and is measured in the arm. Pulmonary hypertension only affects the arteries between the heart and lungs. You can have normal blood pressure in your arm and still have dangerously high pressure in your lungs. They’re completely different conditions with different causes and treatments.

How do I know if my symptoms are PH and not asthma?

Asthma usually causes wheezing, chest tightness, and symptoms that improve with inhalers. PH causes progressive shortness of breath without wheezing, especially with activity, along with swelling in the legs, fatigue, and dizziness. If your breathing gets worse over months despite using asthma meds, or if you have signs like a bulging neck vein or right heart strain on echo, PH should be ruled out. A simple 6-minute walk test and echocardiogram can help differentiate.

What happens if PH is left untreated?

Without treatment, the right side of your heart keeps working harder until it fails. This leads to fluid buildup in the legs, belly, and lungs. You’ll feel constantly tired, dizzy, and short of breath-even at rest. Eventually, your heart can’t pump enough blood. Survival without treatment averages less than 3 years. Early diagnosis and therapy can extend life by decades.

Can I exercise with pulmonary hypertension?

Yes-but carefully. Regular, low-intensity exercise like walking or cycling helps maintain muscle strength and heart function. But intense activity or high-altitude environments can be dangerous. Always work with your PH care team. Many centers offer supervised pulmonary rehab programs. Avoid holding your breath, heavy lifting, or extreme heat. If you feel dizzy, chest pain, or extreme fatigue during exercise, stop immediately and contact your doctor.

about author